35. Pemphigus Clinical trials / Disease details


Clinical trials : 98 Drugs : 126 - (DrugBank : 41) / Drug target genes : 23 - Drug target pathways : 168

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01313923
(ClinicalTrials.gov)
February 201110/3/2011Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis PemphigusEvaluation of Sirolimus for the Treatment of the Autoimmune Blistering Dermatosis PemphigusPemphigusDrug: Sirolimus (formerly known as Rapamycin)University of California, IrvineNULLTerminated18 YearsN/AAll3Early Phase 1United States